glp-1 controversy Hims & Hers, and the Brewing Compounding Sex Differences in the Efficacy

As a result, it generally remains active longer than native IGF-1 under comparable conditions

Clinical trials demonstrate that oral semaglutide can produce meaningful weight reduction when combined with lifestyle changes, though absorption patterns differ from injectable formulations

They concluded that incretin-based medications did not correlate with an increased risk of acute pancreatitis or pancreatic cancer compared to other oral anti-diabetic agents, which remained consistent across drug classification and duration of use [29,55]

Some clinicians may be willing to experiment with lowering your dose to find a maintenance dose, though this practice has not been validated by clinical research and isnt approved by the U.S

GLP-1s Could Treat Type 1 Diabetes Too Another disease primed for GLP-1 expansion is type 1 diabetes